Bitran JD - Search Results

1

CAMP chemotherapy for metastatic non-oat cell bronchogenic carcinoma. A 7-year experience (1975-1981) with 160 patients.

Shepard KV, Golomb HM, Bitran JD, Hoffman PC, Newman SB, DeMeester TR, Skosey C. Shepard KV, et al. Among authors: bitran jd. Cancer. 1985 Nov 15;56(10):2385-90. doi: 10.1002/1097-0142(19851115)56:10<2385::aid-cncr2820561007>3.0.co;2-o. Cancer. 1985. PMID: 3876149

2

Cyclophosphamide, adriamycin, methotrexate, and procarbazine (CAMP)--effective four-drug combination chemotherapy for metastatic non-oat cell bronchogenic carcinoma.

Bitran JD, Desser RK, DeMeester TR, Colman M, Evans R, Billings A, Griem M, Rubenstein L, Shapiro C, Golomb HM. Bitran JD, et al. Cancer Treat Rep. 1976 Sep;60(9):1225-30. Cancer Treat Rep. 1976. PMID: 189920

3

Combined modality therapy for stage IIIMO non-oat cell bronchogenic carcinoma.

Bitran JD, Desser RK, DeMeester T, Shapiro CM, Billings A, Rubenstein L, Evans R, Colman M, Rao CY, Griem M, Golomb HM. Bitran JD, et al. Cancer Treat Rep. 1978 Mar;62(3):327-32. Cancer Treat Rep. 1978. PMID: 348305 Clinical Trial.

4

Metastatic non-oat-cell bronchogenic carcinoma. Therapy with cyclophosphamide, doxorubicin, methotrexate, and procarbazine (CAMP).

Bitran JD, Desser RK, DeMeester T, Golomb HM. Bitran JD, et al. JAMA. 1978 Dec 15;240(25):2743-6. JAMA. 1978. PMID: 713008

5

5-Fluorouracil with oral leucovorin and hydroxyurea and concomitant radiotherapy for stage III non-small cell lung cancer.

Vokes EE, Vijayakumar S, Hoffman PC, Ferguson MK, Bitran JD, Krishnasamy S, Jacobs R, Golomb HM. Vokes EE, et al. Among authors: bitran jd. Cancer. 1990 Aug 1;66(3):437-42. doi: 10.1002/1097-0142(19900801)66:3<437::aid-cncr2820660306>3.0.co;2-c. Cancer. 1990. PMID: 2163744

6

High-dose, multiple-alkylator chemotherapy with autologous bone marrow reinfusion in patients with advanced non-small cell lung cancer.

Williams SF, Bitran JD, Hoffman PC, Robin E, Fullem L, Beschorner J, Golick J, Golomb HM. Williams SF, et al. Among authors: bitran jd. Cancer. 1989 Jan 15;63(2):238-42. doi: 10.1002/1097-0142(19890115)63:2<238::aid-cncr2820630206>3.0.co;2-x. Cancer. 1989. PMID: 2535952

7

A 10-year experience with combined modality therapy for stage III small cell lung carcinoma.

Jacobs RH, Greenburg A, Bitran JD, Hoffman PC, Albain KS, Desser R, Potkul L, Golomb HM. Jacobs RH, et al. Among authors: bitran jd. Cancer. 1986 Nov 15;58(10):2177-84. doi: 10.1002/1097-0142(19861115)58:10<2177::aid-cncr2820581003>3.0.co;2-o. Cancer. 1986. PMID: 3019503

8

Phase II study of carboplatin in previously untreated patients with metastatic small cell lung carcinoma.

Jacobs RH, Bitran JD, Deutsch M, Hoffman PC, Sinkule J, Purl S, Golomb HM. Jacobs RH, et al. Among authors: bitran jd. Cancer Treat Rep. 1987 Mar;71(3):311-2. Cancer Treat Rep. 1987. PMID: 3028621

9

Protochemotherapy in non-small cell lung carcinoma. An attempt to increase surgical resectability and survival. A preliminary report.

Bitran JD, Golomb HM, Hoffman PC, Albain K, Evans R, Little AG, Purl S, Skosey C. Bitran JD, et al. Cancer. 1986 Jan 1;57(1):44-53. doi: 10.1002/1097-0142(19860101)57:1<44::aid-cncr2820570111>3.0.co;2-h. Cancer. 1986. PMID: 3940621

10

Prognostic factors in patients with non-small cell bronchogenic carcinoma and brain metastases.

Robin E, Bitran JD, Golomb HM, Newman S, Hoffman PC, Desser RK, DeMeester TR. Robin E, et al. Among authors: bitran jd. Cancer. 1982 May 1;49(9):1916-9. doi: 10.1002/1097-0142(19820501)49:9<1916::aid-cncr2820490926>3.0.co;2-8. Cancer. 1982. PMID: 6176316

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

170 results

Search Page

Filters